Delivery Order SPE2DB22D1106-SPE2DB25FEKP9

Award Date 4/25/25
Potential Completion Date 5/16/25
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the drug DARZALEX 400 MG/20 ML VIAL 20ML. The $15,511.12 contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. The contract was awarded under a larger indefinite delivery contract (IDC) with a potential value of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a total ceiling value of $55,818.72 and a performance period through April 2, 2024. The contract is for the delivery of DARZALEX 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, in support of military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.40, is for the delivery of DARZALEX FASPR 1800 1S, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,802.10, is for the procurement of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of March 20, 2025. The award was made on February 27, 2025, and there is no set-aside...
This is a $107,355.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a performance period through January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.40, is for the delivery of DARZALEX FASPR 1800 1S medical supplies. The contract has a firm fixed price and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of June 13, 2025. The contract is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,060.79 firm fixed-price delivery order is for the supply of DARZALEX 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a performance period through May 30, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor for this award, which is part...
This is a $59,802.10 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, with a completion date of April 1, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,685.76 firm fixed-price contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has an ultimate completion date of August 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEKP9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,747.72, is for the supply of 4,568,038,477 units of the pharmaceutical product DARZALEX 400 MG/20 ML VIAL 20ML. The contract is a firm fixed-price delivery order, with a period of performance extending through May 16, 2025. AmerisourceBergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 7/25/25, 11:28 AM